ArticleDiagnostics (Basel, Switzerland)2023

CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies.

Elisabetta Zanatta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.